Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. CA Cancer J Clin 66:115–32.
   PubMed Web of Science ®Google Scholar
• Bijelic L, Sugarbaker PH. (2012). The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. Ann Ital Chir 83:224–31.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Canbay E, Li Y, et al. (2016). A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol 42:1123–31.
   PubMed Web of Science ®Google Scholar
• Thomassen I, Van Gestel YR, Van Ramshorst B, et al. (2014). Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134:622–8.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou YF, Liang H, et al. (2016). Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 22:6906–16.
   PubMed Web of Science ®Google Scholar
• Roviello F, Marrelli D, De Manzoni G, et al. (2003). Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–19.
   PubMed Web of Science ®Google Scholar
• Sakuramoto S, Sasako M, Yamaguchi T, et al. (2007). Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–20.
   PubMed Web of Science ®Google Scholar
• Yu JI, Lim Do H, Ahn YC, et al. (2015). Effects of adjuvant radiotherapy on completely resected gastric cancer: a radiation oncologist’s view of the ARTIST randomized phase III trial. Radiother Oncol 117:171–7.
   PubMed Web of Science ®Google Scholar
• Cao L, Selby LV, Hu X, et al. (2016). Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China. J Surg Oncol 113:745–9.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee CM, Son SY, et al. (2014). Laparoscopic versus open gastrectomy for gastric cancer: long-term oncologic results. Surgery 155:154–64.
   PubMed Web of Science ®Google Scholar
• Sadeghi B, Arvieux C, Glehen O, et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–63.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Suo T, et al. (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18:1575–81.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Arvieux C, et al. (2010). Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–7.
   PubMed Web of Science ®Google Scholar
• Rudloff U, Langan RC, Mullinax JE, et al. (2014). Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110:275–84.
   PubMed Web of Science ®Google Scholar
• Yang XJ, Li Y, Yonemura Y. (2010). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center. J Surg Oncol 101:457–64.
   PubMed Web of Science ®Google Scholar
• Glehen O, Schreiber V, Cotte E, et al. (2004). Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139:20–6.
   PubMed Web of Science ®Google Scholar
• Beaujard AC, Glehen O, Caillot JL, et al. (2000). Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2512–9.
   PubMed Web of Science ®Google Scholar
• Wu HT, Peng KW, Ji ZH, et al. (2016). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: results from a Chinese center. Eur J Surg Oncol 42:1024–34.
   PubMed Web of Science ®Google Scholar
• Tu Y, Tian Y, Fang Z, et al. (2016). Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: a single-centre retrospective study. Int J Hyperthermia 32:587–94.
   PubMed Web of Science ®Google Scholar
• Boerner T, Graichen A, Jeiter T, et al. CRS-HIPEC prolongs survival but is not curative for patients with peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol 23:3972–7.
   PubMed Web of Science ®Google Scholar
• Passot G, Vaudoyer D, Villeneuve L, et al. (2016). What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol 113:796–803.
   PubMed Web of Science ®Google Scholar
• Desantis M, Bernard JL, Casanova V, et al. (2015). Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 400:37–48.
   PubMed Web of Science ®Google Scholar
• Yarema RR, Ohorchak MA, Zubarev GP, et al. (2014). Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: results of a single-centre retrospective study. Int J Hyperthermia 30:159–65.
   PubMed Web of Science ®Google Scholar
• Magge D, Zenati M, Mavanur A, et al. (2014). Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol 21:1448–55.
   PubMed Web of Science ®Google Scholar
• Muller H, Hotopp T, Tofeili A, Wutke K. (2014). Systemic chemotherapy using FLOT – regimen combined with cytoreductive surgery plus HIPEC for treatment of peritoneal metastasized gastric cancer. Hepatogastroenterology 61:703–6.
   PubMedGoogle Scholar
• Konigsrainer I, Horvath P, Struller F, et al. (2014). Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases. J Gastric Cancer 14:117–22.
   PubMedGoogle Scholar
• Canbay E, Mizumoto A, Ichinose M, et al. (2014). Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol 21:1147–52.
   PubMed Web of Science ®Google Scholar
• Schildberg CW, Weidinger T, Hohenberger W, et al. (2014). Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis. World J Surg 38:419–25.
   PubMed Web of Science ®Google Scholar
• Kang LY, Mok KT, Liu SI, et al. (2013). Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. J Chin Med Assoc 76:425–31.
   PubMed Web of Science ®Google Scholar
• Hultman B, Lind P, Glimelius B, et al. (2013). Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy. Acta Oncol 52:824–30.
   PubMed Web of Science ®Google Scholar
• Shen P, Stewart JHT, Levine EA. (2009). Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications. Curr Probl Cancer 33:168–93.
   PubMed Web of Science ®Google Scholar
• Scaringi S, Kianmanesh R, Sabate JM, et al. (2008). Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. Eur J Surg Oncol 34:1246–52.
   PubMed Web of Science ®Google Scholar
• Zhu ZG, Tang R, Yan M, et al. (2006). Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study. Dig Surg 23:93–102.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Kawamura T, Bandou E, et al. (2005).Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370–5.
   PubMed Web of Science ®Google Scholar
• Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, Mcquellon R, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004; 8:454–63.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Yonemura Y, Nakagawara H, et al. (2000). Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. Oncol Rep 7:809–14.
   PubMed Web of Science ®Google Scholar
• Hirose K, Katayama K, Iida A, et al. (1999). Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis. Oncology 57:106–14.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Fujimura T, Nishimura G, et al. (1996). Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119:437–44.
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Fujimura T, Fushida S, et al. (1991). Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 15:530–5.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Takahashi M, Mutou T, et al. (1997). Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79:884–91.
   PubMed Web of Science ®Google Scholar
• Averbach AM, Jacquet P. (1996). Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 83:726–33.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat Rev 48:42–9.
   PubMed Web of Science ®Google Scholar
• Seshadri RA, Glehen O. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 22:1114–30.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (2001). Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27:239–43.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1999). Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43:S15–S25.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Boutitie F, et al. (2010). Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–18.
   PubMed Web of Science ®Google Scholar
• Levine EA, Stewart JHT, Shen P, et al. (2014).Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg 218:573–85.
   PubMed Web of Science ®Google Scholar
• Glehen O, Mohamed F, Gilly FN. (2004). Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–28.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Campanati L, Catena F, et al. (2015). Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. J Gynecol Oncol 26:54–61.
   PubMed Web of Science ®Google Scholar